Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophrenia

European Archives of Psychiatry and Clinical Neuroscience

Volumn 247, Issue 6, 1997, Pages 308-313

  Müller, Norbert ^a   Empl, Monika ^a   Riedel, Michael ^a   Schwarz, Markus ^a   Ackenheil, Manfred ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Immunology; Neuroleptics; Schizophrenia; sIL 2R; sIL 6R

Indexed keywords

BUTYROPHENONE DERIVATIVE; CLOZAPINE; CYTOKINE; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; NEUROLEPTIC AGENT; PHENOTHIAZINE DERIVATIVE;

ADULT; ARTICLE; ASTROCYTE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; MALE; MICROGLIA; NEUROTRANSMISSION; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0031434889     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02922260     Document Type: Article

References (55)

1. American Psychiatric Association (1990) Structured clinical interview for DSM-III-R. American Psychiatric Press, Washington DC
2. American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders (DSM-III-R), 3rd edn, revised. American Psychiatric Press, Washington DC
3. Baker GA, Syntalo R, Blumenstein J (1977) Effects of psychotropic agents upon the blastogenic response on human T-lymphocytes. Biol Psychiatry 12: 159-169
4. Banks WA, Kastin AJ (1992) The interleukins-1 alpha, -1 beta, and -2 do not acutely disrupt the murine blood-brain barrier. Int J Immunopharmacol 14: 629-636
5. Barral-Netto M, Barrai A, Santos SB, Carvalho EM, Badaro R, Rocha H, Reed SG, Johnson WD Jr (1991) Soluble IL-2 receptors as an agent of serum-mediated suppression in human visceral leishmaniasis. J Immunol 147: 281-284
6. Bessler H, Levental Z, Karp L, Modai I, Djaldetti M, Weizman A (1995) Cytokine production in drug-free and neuroleptic-treated schizophrenic patients. Biol Psychiatry 38: 297-302
7. Brivio S, Lissoni P, Mancini D, Tisi E, Tancini G, Barni S, Nociti V (1991) Effect of antitumor surgery on soluble interleukin-2 receptor serum levels. Am J Surg 161: 466-469
8. Damle RN, Advani SH, Gangal SG (1992) Analysis of regulation of T-cell responses by soluble inhibitory factors from the sera of patients with Hodgkin's disease. Int J Cancer 50: 192-196
9. Denicoff KD, Rubinoff DR, Papa MZ, Simpson C, Seipp CA, Lotze MT, Chang AE, Rosenstein D, Rosenberg SA (1987) The neuropsychiatric effects of treatment with Interleukin-2 and lymphokine-activated killer cells. Ann Intern Med 107: 293-300
10. Gallien M, Schnetzler JP, Morin J (1977) Antinucleur antibodies and lupus cells in 600 hospitalized phenothiazine treated patients. Ann Med Psychol Med 1: 237-248
11. Ganguli R, Rabin BS (1989) Increased serum Interleukin 2 receptor levels in schizophrenic and brain damaged subjects. Arch Gen Psychiatry 46: 292
12. Ganguli R, Yang Z, Shurin G, Chengappa R, Brar JS, Guhbi AV. Rabin BS (1994) Serum Interleukin-6 concentration in schizophrenia: elevation associated with duration of illness. Psychiatry Res 51:1-10
13. Ganguli R, Brar JS, Chengappa KR, DeLeo M, Yang ZW, Shurin G, Rabin B (1995a) Mitogen-stimulated interleukin 2 production in never-medicated, first episode schizophrenics: the influence of age of onset and negative symptoms. Arch Gen Psychiatry 52: 878
14. Ganguli R, Brar JS, Rabin BS (1995b) Reply on: Pollmächer T et al. Clozapine-induced increase in plasma levels of soluble interleukin-2 receptors. Arch Gen Psychiatry 52: 668-672
15. Hama T, Kushima Y, Miyamoto M, Kubota M, Takei N, Hatanaka H (1991) Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week-old rats in cultures. Neuroscience 40: 445-452
16. Hornberg M, Arolt V, Wilke I, Kruse A, Kirchner H (1995) Production of interferons and lymphokines in leukocyte cultures of patients with schizophrenia. Schizophr Res 15: 237-242
17. Hornung N, Raskova J, Raska K, Degiannis D (1992) Il-2 responsiveness of lectin-induced lymphoblasts: soluble IL-2 receptor release and differential in vitro effects of immunosuppressants. Int J Immunopharmacol 14: 753-760
18. Kay SR, Oppler LA, Fiszbein A (1986) Positive and negative syndrome scale (PANSS) manual. Multi-Health Systems. North Tonawanda, New York
19. Licinio J, Seibyl JP, Altemus M, Charney DS, Krystal JH (1993) Elevated levels of Interleukin-2 in neuroleptic-free schizophrenics. Am J Psychiatry 150:1408-1410
20. Mackiewicz A, Schooltink H, Heinrich PC, Rose-John S (1992) Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins. J Immunol 49: 2021-2027
21. Maes M, Meltzer HY, Bosmans E (1994) Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine. Acta Psychiatr Scand 89: 346-351
22. Maes M, Bosmans E, Ranjan R, Vandoolaeghe B, Meltzer HY, Ley M de, Berghmans R, Stans G, Desnyder R (1996) Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs. Schizophr Res 21: 39-50
23. McAllister CG, Rapaport MH, Pickar D, Paul SM (1989) Effect of short-term administration of antipsychotic drugs on lymphocyte subsets in schizophrenic patients. Arch Gen Psychiatry 46: 956-957
24. McAllister CG, van Kammen DP, Rehn TJ, Miller AL, Gurklis J, Kelley ME, Yao J, Peters JL (1995) Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status. Am J Psychiatry 152: 1291-1297
25. Müller N, Ackenheil M (1995) Immunoglobulin and albumin contents of cerebrospinal fluid in schizophrenic patients: the relationship to negative symptomatology. Schizophr Res 14: 223-228
26. Müller N (1997) The role of the cytokine network in the CNS and psychic disorders. Nervenarzt 68: 11-20
27. Müller N, Ackenheil M, Hofschuster E, Mempel W, Eckstein R (1991) Cellular immunity in schizophrenic patients before and during neuroleptic therapy. Psychiatry Res 37:147-160
28. Müller N, Empel M, Putz A, Schwarz M, Ackenheil M (1997a) Immunological effects of treatment in schizophrenia. In: Henneberg AE, Kaschka WP (eds) Immunological alterations in psychiatric diseases. Karger, Basel, pp 78-84
29. Müller N, Dobmeier P, Empel M, Riedel M, Schwarz M, Ackenheil M (1997b) Soluble IL-6 Receptors in the serum and cerebrospinal fluid of paranoid schizophrenic patients. Eur Psychiatry 12: 294-299
30. Müller N, Hadjamu M, Riedel M, Primbs J, Ackenheil M, Gruber R (submitted) The adhesion-molecule receptor expression on T helper cells increases during treatment with neuroleptics and is related to the blood-brain barrier permeability in schizophrenia. Am J Psychiatry
31. Norris JG, Benveniste EN (1993) Interleukin-6 production by astrocytes: induction by the neurotransmitter norepinephrine. J Neuroimmunol 45:137-146
32. Plata-Salaman CR (1991) Immunoregulators in the nervous system. Neurosci Behav Rev 15: 185-215
33. Plata-Salaman CR, Ffrench-Mullen JM (1993) Interleukin-2 modulates calcium currents in dissociated hippocampal CA1 neurons. Neuroreport 4: 579-581
34. Pollmächer T, Hinze-Seich D, Mullington J, Holsboer F (1995) Clozapine-induced increase in plasma levels of soluble Interleukin-2 receptors. Arch Gen Psychiatry 52: 877-878
35. Ransohoff RM, Benveniste EN (1996) Cytokines and the CNS. CNC Press NY, London
36. Rapaport MH, McAllister CG, Pickar D, Nelson DM, Paul SM (1989) Elevated levels of soluble interleukin-2 receptors in schizophrenia. Arch Gen Psychiatry 46:292
37. Rapaport MH, McAllister CG, Kirch DG, Pickar D (1990) The effects of typical and atypical neuroleptics on mitogen-induced T lymphocyte responsiveness. Biol Psychiatry 29: 715-717
38. Rapaport MH, Doran AR, Nelson DM, McAllister CG, Magliozzi JR, Paul SM (1991) Haloperidol and soluble Interleukin-2 receptors. Biol Psychiatry 30: 1063-1065
39. Rapaport MH, Torrey EF, McAllister CG, Nelson DM, Pickar D, Paul SM (1993) Increased serum soluble interleukin-2 receptors in schizophrenic monozygotic twins. Eur Arch Psychiatry Clin Neurosci 243: 7-10
40. Rapaport MH, McAllister CG, Kim YS, Han JH, Pickar D, Nelson DM, Kirch DG, Paul SM (1994) Increased soluble Interleukin-2 receptors in Caucasian and korean schizophrenic patients. Biol Psychiatry 35: 767-771
41. Reiber H, Felgenhauer K (1987) Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin Chem Acta 163: 319-328
42. Russo R, Ciminale M, Ditommaso S, Siliquini R, Zotti C, Ruggenini AM (1994) Hepatitis B vaccination in psychiatric patients. Lancet I 343: 394
43. Saunders JC, Muchmore E (1964) Phenothiazine effect on human antibody synthesis. Br J Psychiatry 110: 84-89
44. Sawada M, Suzumura A, Marunouchi T (1992) TNF-alpha induces IL-6 production by astrocytes, but not by microglia. Brain Res 583: 296-299
45. Schleuning MJ, Duggan A, Reem GH (1989) Inhibition by chlorpromazine of lymphokine-specific mRNA expression in human thymocytes. Eur J Immunol 19: 1491-1496
46. Schleuning M, Brumme V, Wilmanns W (1994) Inhibition of cyclosporin A/FK 506 resistant, lymphokine-induced T-cell activation by phenothiazine derivates. Naunyn-Schmiedeberg's Arch Pharmacol 350: 100-103
47. Schöbitz B, Pezeshki G, Pohl T, Hermann U, Heinrich PC, Holsboer F, Reul JM (1995) Soluble interleukin-6 (IL-6) receptor augments central effects of IL-6 in vivo. FASEB J 9: 659-664
48. Smith RS (1991) Is schizophrenia caused by excessive production of interleukin-2 and interleukin-2 receptors by gastrointestinal lymphocytes? Med Hypotheses 34: 225-229
49. Smith RS (1992) A comprehensive macrophage-T-lymphocyte theory of schizophrenia. Med Hypotheses 39: 248-257
50. Tibbling G, Link H, Ohmann S (1977) Principles of albumin and IgG analyses in neurological disorders. I: Establishment of reference values. Scand J Clin Lab Invest 37: 385-390
51. Villemain F, Chatenoud L, Galinowski A, Homo-Delarche F, Genestet D, Loo H, Zarifarain E, Bach JF (1989) Aberrant T-cell-mediated immunity in untreated schizophrenic patients: deficient interleukin-2 production. Am J Psychiatry 146: 609-616
52. Waguespack PJ, Banks WA, Kastin AJ (1994) Interleukin-2 does not cross the blood-brain barrier by a saturable transport system. Brain Res Bull 34: 103-109
53. Wilke I, Arolt V, Rothermundt M, Weitzsch Ch, Hornberg M, Kirchner H (1996) Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients. Eur Arch Psychiatry Clin Neurosci 246: 279-284
54. Zalcman S, Green-Johnson JM, Murray L, Nance DM, Dyck D, Anisman H, Greenberg AH (1994) Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. Brain Res 643: 40-49
55. Zarrabi MH, Zucker S, Miller F, Derman RM, Romeno GS, Hartnett JA, Varma AO (1979) Immunologic and coagulation disorders in chlorpromazine-treated patients. Ann Int Med 91: 194-199